Skip to main content
Premium Trial:

Request an Annual Quote

Circulomics Receives NIH Grant to Develop FFPE DNA/RNA Extraction Technology

NEW YORK (GenomeWeb) – Circulomics announced today that it has received a Phase I Small Business Innovation Research grant from the National Institutes of Health to develop its Nanobind DNA and RNA isolation technology for formalin-fixed, paraffin-embedded (FFPE) samples.

The one-year grant, which began on Sept. 1, is worth $224,338.

According to the company, the Nanobind technology is based on inexpensive thermoplastic material containing a hierarchical structure of microscale folds topped by nanoscale wrinkles, which create a high surface area silica substrate that can bind and release large amounts of high molecular weight DNA and RNA without fragmenting it.

Nanobind-isolated DNA and RNA, the company stated in its grant abstract, has an integrity on par with phenolchloroform extraction, but are obtained through a process simpler than beads and spin columns.

With the NIH funding, Circulomics aims to develop a method to extract RNA-free DNA from FFPE samples and modify the extraction protocols for obtaining DNA-free RNA. The company will validate the Nanobind approach for molecular profiling by performing methylation, mutation, and microRNA analysis using qMSP, qPCR, and RT-qPCR, and comparing its performance to commercial column-extracted DNA and RNA.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.